Top Nine Organics: Announcement on not redeeming the top nine convertible bonds early
Jiuqiang Biotech: China International Finance Corporation\'s inspection opinion on Beijing Jiuqiang Biotechnology Co., Ltd. not redeeming Jiuqiang Biotech Co., Ltd.\'s transfer debt in advance
Top 9 Biotech: An indicative announcement that the top nine convertible bonds may meet the redemption conditions
Jiuqiang Biotech: Announcement on the progress of the acquisition of shares in Fuzhou Maixin Biotechnology Development Co., Ltd.
Jiuqiang Biotech: Announcement on the acquisition of shares in Fuzhou Maixin Biotechnology Development Co., Ltd.
Jiuqiang Biotech: Announcement on short-term convertible debt transactions involving relatives of executives
Jiuqiang Biology: Legal opinion of Beijing Haiwen Law Firm on the issuance of convertible corporate bonds by Beijing Jiuqiang Biotechnology Co., Ltd. to unspecified targets and listed on the Shenzhen Stock Exchange
Jiuqiang Biotech: Announcement on convertible corporate bond pledges for shareholders holding 5% or more of the company's shares
Jiuqiang Biotech: An indicative announcement from the GEM of Beijing Jiuqiang Biotechnology Co., Ltd. issuing a prospectus for convertible corporate bonds to unspecified targets
Jiuqiang Biotech: Online roadshow announcement on the issuance of convertible corporate bonds by the GEM board of Beijing Jiuqiang Biotechnology Co., Ltd. to unspecified targets
Jiuqiang Biotech: Announcement on the company's application for issuing convertible corporate bonds to unspecified targets and obtaining approval for registration from the China Securities Regulatory Commission
Top Nine Organisms: 2021 Annual Equity Distribution Implementation Notice
Jiuqiang Biotech: Response report of Beijing Jiuqiang Biotechnology Co., Ltd. and China International Finance Corporation on the implementation letter of feedback on the issuance registration process of Beijing Jiuqiang Biotechnology Co., Ltd.'s applicatio
Jiuqiang Biotech: Beijing Haiwen Law Firm's Supplementary Legal Opinion on the Issuance of Convertible Corporate Bonds by Beijing Jiuqiang Biotechnology Co., Ltd. to Unspecified Targets (3) (Revised Draft)
Jiuqiang Biotech: Supplemental Legal Opinions from 3 Law Firms (Revised Draft)
Top 9 Biotech: 2 Accounting Firms Respond to Comments
Nine Biotech: 1 Response to Comments from Applicants and Sponsors (Revised Draft)
Jiuqiang Biotech: Verification opinion of Huachuang Securities Co., Ltd. on the fulfillment of the 2021 performance promises of major asset purchases and related transactions of Beijing Jiuqiang Biotechnology Co., Ltd.
Jiuqiang Biotech: Huacheng Securities Co., Ltd.'s 2021 Continued Supervision Opinions and Continued Supervision Summary Report on Major Asset Purchases and Related Transactions of Beijing Jiuqiang Biotechnology Co., Ltd.
Top 9 Biotech: Announcement on 2021 Profit Distribution Plan
No Data